✦ LIBER ✦

Phase II Study of Low-Dose Docetaxel/Estramustine in Elderly Patients or Patients Aged 18-74 Years with Hormone-Refractory Prostate Cancer

✍ Scribed by Sreeni Chittoor; William Berry; David Loesch; Keith Logie; John Fleagle; Stephanie Mull; Kristi A. Boehm; Feng Zhan; Lina Asmar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase-II Study of Docetaxel, Estramustin

✍ Nobuyuki Kikuno; Shinji Urakami; Shigeru Nakamura; Takeo Hiraoka; Taijyu Hyuga; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Docetaxel in combination with estramusti

✍ António Canelas 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A randomized study of docetaxel and dexa

✍ THOMAS NELIUS; TOBIAS KLATTE; RON YAP; THOMAS KALINSKI; ALBRECHT RÖPKE; STEPHANI 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Phase II study of sequential chemotherap

✍ Galli, L; Fontana, A; Galli, C; Landi, L; Fontana, E; Antonuzzo, A; Andreuccetti 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

A phase I/II dose-escalation study of ex

✍ Christopher W. Ryan; Walter M. Stadler; Nicholas J. Vogelzang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

RANDOMISED STUDY OF DOCETAXEL (D) AND DE

✍ T. Nelius; T. Klatte; F. Reiher; R. Yap; E.P. Allhoff 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 52 KB